The Cooper Companies Inc (COO) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
The Cooper Companies Inc   (NASDAQ: COO)
 

The Cooper Companies Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, The Cooper Companies Inc 's inventory turnover ratio sequentially decreased to 1.65 in the third quarter 2026, unsurprisingly, as the The Cooper Companies Inc markets continue to deteriorate, and COO's faces growing challenges to bring down its inventories. The Cooper Companies Inc 's average inventory processing period in the Jul 31 2026 quarter, has increased to 221 days, from 217 days, in the Apr 30 2026 quarter.

Within Healthcare sector 242 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1605 in the second quarter 2026, to 1670.

COO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is The Cooper Companies Inc Market Share?

What is Inventory Turnover Ratio?




COO Inventory Turnover Ratio (Jul 31 2026)
III. Quarter
(Apr 30 2026)
II. Quarter
(Jan 31 2026)
I. Quarter
(Oct 31 2025)
IV. Quarter
(Jul 31 2025)
III. Quarter
Y / Y Inventory Growth 3.46 % 1.83 % 5.39 % 5.39 % 13.05 %
Y / Y Cost of Sales Growth -3.72 % 7.12 % 7.89 % 21.81 % 8.55 %
Inventory Turnover Ratio (TTM) 1.65 1.68 1.66 1.65 1.59
COO's Total Ranking # 1670 # 1605 # 1198 # 1506 # 1401
Average inventory processing period 221 217 220 221 230
Seq. Inventory Growth 1.68 % 5.96 % 0 % -3.97 % 0.08 %
Seq. Cost of Sales Growth 2.4 % 5.49 % -20.96 % 12.77 % 13.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 109
Healthcare Sector # 243
Overall Market # 1670

Inventory Turnover Ratio Statistics
High Average Low
1.93 1.7 1.25
(Jan 31 2023)   (Jul 31 2013)




Financial Statements
The Cooper Companies Inc 's Inventories $ 912 Millions Visit COO's Balance sheet
The Cooper Companies Inc 's Cost of Revenues TTM $ 1,443 Millions Visit COO's Income Statement
What are COO's Sales? Visit COO's Sales by Segment

Other Inventory Turnover Ratios
The Cooper Companies Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
COO's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for COO's Competitors
Inventory Turnover Ratio for COO's Suppliers
Inventory Turnover Ratio for COO's Customers

You may also want to know
COO's Sales Growth Rates COO's Pe Price to earnings ratio COO's Receivables Turnover Ratio COO's Stock Quote
COO's Net Income Growth Rates COO's Ps Price to Sales ratio COO's Sales per Employee COO's Asset Turnover Ratio
COO's Net Margin COO's Pb Price to Book ratio COO's Financial Strength Ratios COO's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jul 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jul 31 2026 Inventories at quarter ending Jul 31 2026
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions
Intelligent Bio Solutions Inc   3.80 $ 2.165  Millions$ 1  Millions
Iridex Corp  3.80 $ 32.517  Millions$ 9  Millions
Biocryst Pharmaceuticals Inc   3.69 $ 20.926  Millions$ 6  Millions
Abbvie Inc   3.66 $ 18,365.000  Millions$ 5,016  Millions
Teva Pharmaceutical Industries Limited  3.66 $ 8,232.000  Millions$ 2,250  Millions
Neuraxis Inc   3.55 $ 0.783  Millions$ 0  Millions
Beyond Air Inc   3.51 $ 6.447  Millions$ 2  Millions
Nexgel Inc   3.49 $ 7.577  Millions$ 2  Millions
Lifeward ltd   3.47 $ 13.976  Millions$ 4  Millions
Tandem Diabetes Care Inc   3.46 $ 456.703  Millions$ 132  Millions
Baxter International Inc   3.46 $ 8,020.000  Millions$ 2,317  Millions
Mirum Pharmaceuticals Inc   3.40 $ 85.221  Millions$ 25  Millions
Zai Lab Limited  3.39 $ 195.542  Millions$ 58  Millions
Cadre Holdings inc   3.39 $ 399.991  Millions$ 118  Millions

Date modified: 2026-10-05T11:03:41+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.